• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过点突变和缺失对neu编码的受体蛋白进行致癌激活。

Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion.

作者信息

Bargmann C I, Weinberg R A

机构信息

Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge 01242.

出版信息

EMBO J. 1988 Jul;7(7):2043-52. doi: 10.1002/j.1460-2075.1988.tb03044.x.

DOI:10.1002/j.1460-2075.1988.tb03044.x
PMID:2901345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC454481/
Abstract

The rat neu gene, which encodes a receptor-like protein homologous to the epidermal growth factor receptor, is frequently activated by a point mutation altering a valine residue to a glutamic acid residue in its predicted transmembrane domain. Additional point mutations have been constructed in a normal neu cDNA at and around amino acid position 664, the site of the naturally arising mutation. A mutation which causes a substitution of a glutamine residue for the normal valine at residue 664 leads to full oncogenic activation of the neu gene, but five other substitutions do not. Substituted glutamic acid residues at amino acid positions 663 or 665 do not activate the neu gene. Thus only a few specific residues at amino acid residue 664 can activate the oncogenic potential of the neu gene. Deletion of sequences of the transforming neu gene demonstrates that no more than 420 amino acids of the 1260 encoded by the gene are required for full transforming function. Mutagenesis of the transforming clone demonstrates a correlation between transforming activity and tyrosine kinase activity. These data indicate that the activating point mutation induces transformation through (or together with) the activities of the tyrosine kinase.

摘要

大鼠neu基因编码一种与表皮生长因子受体同源的受体样蛋白,该基因经常通过一个点突变而被激活,此突变在其预测的跨膜结构域中将一个缬氨酸残基改变为谷氨酸残基。在正常的neu cDNA中,已在天然发生突变的位点(氨基酸位置664及其周围)构建了额外的点突变。在第664位残基处,一个导致正常缬氨酸被谷氨酰胺残基取代的突变会导致neu基因完全致癌激活,但其他五个取代则不会。在氨基酸位置663或665处的取代谷氨酸残基不会激活neu基因。因此,只有在氨基酸残基664处的少数特定残基才能激活neu基因的致癌潜能。对转化性neu基因序列的缺失表明,该基因编码的1260个氨基酸中,不超过420个氨基酸对于完全转化功能是必需的。对转化性克隆的诱变表明转化活性与酪氨酸激酶活性之间存在相关性。这些数据表明,激活点突变通过酪氨酸激酶的活性(或与之一起)诱导转化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda3/454481/aaf22107c9ba/emboj00144-0125-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda3/454481/e6dd7fa5487a/emboj00144-0122-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda3/454481/2967673e1494/emboj00144-0123-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda3/454481/da85d399a3b1/emboj00144-0125-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda3/454481/aaf22107c9ba/emboj00144-0125-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda3/454481/e6dd7fa5487a/emboj00144-0122-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda3/454481/2967673e1494/emboj00144-0123-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda3/454481/da85d399a3b1/emboj00144-0125-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda3/454481/aaf22107c9ba/emboj00144-0125-b.jpg

相似文献

1
Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion.通过点突变和缺失对neu编码的受体蛋白进行致癌激活。
EMBO J. 1988 Jul;7(7):2043-52. doi: 10.1002/j.1460-2075.1988.tb03044.x.
2
Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases.昆虫细胞表达的neu酪氨酸激酶正常形式与致癌形式的生化比较。
J Biol Chem. 1992 Jul 15;267(20):13851-6.
3
An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.一种致癌点突变使神经受体具有高亲和力配体结合能力。对位点异质性产生的影响。
J Biol Chem. 1992 Aug 25;267(24):17304-13.
4
Enhancement of tyrosine kinase activity of the Drosophila epidermal growth factor receptor homolog by alterations of the transmembrane domain.
Eur J Biochem. 1990 May 20;189(3):637-45. doi: 10.1111/j.1432-1033.1990.tb15532.x.
5
Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.表皮生长因子诱导的磷酸化过程改变致癌性和细胞neu(NGL)基因产物。
Proc Natl Acad Sci U S A. 1988 Aug;85(15):5389-93. doi: 10.1073/pnas.85.15.5389.
6
A subdomain in the transmembrane domain is necessary for p185neu* activation.跨膜结构域中的一个亚结构域对于p185neu*激活是必需的。
EMBO J. 1992 Mar;11(3):923-32. doi: 10.1002/j.1460-2075.1992.tb05131.x.
7
Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.通过点突变改变p185跨膜结构域而导致neu癌基因的多次独立激活。
Cell. 1986 Jun 6;45(5):649-57. doi: 10.1016/0092-8674(86)90779-8.
8
Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product.
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7335-9. doi: 10.1073/pnas.89.16.7335.
9
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.neu原癌基因中的一个点突变模拟了配体诱导的受体聚集。
Nature. 1989 May 18;339(6221):230-1. doi: 10.1038/339230a0.
10
Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of the neu oncogene-encoded p185 protein.
J Protein Chem. 1989 Dec;8(6):749-56. doi: 10.1007/BF01024899.

引用本文的文献

1
Tumor diagnosis using carbon-based quantum dots: Detection based on the hallmarks of cancer.基于碳基量子点的肿瘤诊断:基于癌症特征的检测
Bioact Mater. 2023 Nov 15;33:174-222. doi: 10.1016/j.bioactmat.2023.10.004. eCollection 2024 Mar.
2
Cell lineage tracing links ERα loss in Erbb2-positive breast cancers to the arising of a highly aggressive breast cancer subtype.细胞谱系追踪将 Erbb2 阳性乳腺癌中 ERα 的丢失与一种高度侵袭性乳腺癌亚型的出现联系起来。
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2100673118.
3
Expression and Functional Study of Single Mutations of Carbonic Anhydrase 8 in Neuronal Cells.

本文引用的文献

1
Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts.将癌和神经母细胞瘤的转化基因导入小鼠成纤维细胞。
Nature. 1981 Mar 19;290(5803):261-4. doi: 10.1038/290261a0.
2
Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas.大鼠神经母细胞瘤转化DNA特异性诱导的一种磷蛋白的鉴定。
Cell. 1982 Apr;28(4):865-71. doi: 10.1016/0092-8674(82)90065-4.
3
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.逆转录病毒包装突变体的构建及其用于产生无辅助病毒的缺陷型逆转录病毒。
碳酸酐酶 8 单突变在神经元细胞中的表达和功能研究。
Cell Mol Neurobiol. 2021 Aug;41(6):1355-1371. doi: 10.1007/s10571-020-00907-1. Epub 2020 Jun 24.
4
Driving the catalytic activity of a transmembrane thermosensor kinase.驱动跨膜热传感器激酶的催化活性。
Cell Mol Life Sci. 2020 Oct;77(19):3905-3912. doi: 10.1007/s00018-019-03400-1. Epub 2019 Dec 4.
5
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.唐氏综合征患儿骨髓性前期白血病向转化性骨髓性白血病进展的机制。
Cancer Cell. 2019 Aug 12;36(2):123-138.e10. doi: 10.1016/j.ccell.2019.06.007. Epub 2019 Jul 11.
6
Modulation of Transmembrane Domain Interactions in Neu Receptor Tyrosine Kinase by Membrane Fluidity and Cholesterol.神经受体酪氨酸激酶跨膜结构域相互作用的调制:膜流动性和胆固醇的影响。
J Membr Biol. 2019 Oct;252(4-5):357-369. doi: 10.1007/s00232-019-00075-4. Epub 2019 Jun 20.
7
Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations.可操作的激活致癌 ERBB2/HER2 跨膜和近膜结构域突变。
Cancer Cell. 2018 Nov 12;34(5):792-806.e5. doi: 10.1016/j.ccell.2018.09.010. Epub 2018 Oct 25.
8
His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor.组氨酸499调节二聚化并防止人血小板生成素受体天冬酰胺突变引起的致癌激活。
J Biol Chem. 2016 Feb 5;291(6):2974-87. doi: 10.1074/jbc.M115.696534. Epub 2015 Dec 1.
9
Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.ERBB2突变对膀胱癌体外拉帕替尼敏感性的影响。
Cancer Biol Ther. 2014 Sep;15(9):1239-47. doi: 10.4161/cbt.29687. Epub 2014 Jul 14.
10
Strong dimerization of wild-type ErbB2/Neu transmembrane domain and the oncogenic Val664Glu mutant in mammalian plasma membranes.野生型ErbB2/Neu跨膜结构域与致癌性Val664Glu突变体在哺乳动物质膜中的强烈二聚化。
Biochim Biophys Acta. 2014 Sep;1838(9):2326-30. doi: 10.1016/j.bbamem.2014.03.001. Epub 2014 Mar 11.
Cell. 1983 May;33(1):153-9. doi: 10.1016/0092-8674(83)90344-6.
4
Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene.单克隆抗体识别一种与活化细胞癌基因相关的细胞表面抗原。
Nature. 1984;312(5994):545-8. doi: 10.1038/312545a0.
5
The molecular genetics of cellular oncogenes.细胞癌基因的分子遗传学
Annu Rev Genet. 1984;18:553-612. doi: 10.1146/annurev.ge.18.120184.003005.
6
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.人表皮生长因子受体cDNA序列及扩增基因在A431表皮样癌细胞中的异常表达。
Nature. 1984;309(5967):418-25. doi: 10.1038/309418a0.
7
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.表皮生长因子受体与v-erb-B癌基因蛋白序列的高度相似性。
Nature. 1984;307(5951):521-7. doi: 10.1038/307521a0.
8
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.利用处于SV40早期区域启动子控制下的细菌基因将哺乳动物细胞转化为抗生素抗性细胞。
J Mol Appl Genet. 1982;1(4):327-41.
9
Sequencing end-labeled DNA with base-specific chemical cleavages.通过碱基特异性化学切割对末端标记的DNA进行测序。
Methods Enzymol. 1980;65(1):499-560. doi: 10.1016/s0076-6879(80)65059-9.
10
The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity.ras的产物是一种GTP酶,而T24致癌突变体在这种活性方面存在缺陷。
Nature. 1984;311(5983):273-5. doi: 10.1038/311273a0.